Perceptive's third credit fund has $1.1B in 'incremental capital' for growing biotech and healthcare companies
Two years after wrapping its second Credit Opportunities Fund with $675 million, longtime VC Perceptive Advisors hit the hard cap on its third — raising $1.1 billion to pump into biotech and healthcare.
The firm initially set out to raise $750 million, according to Sam Chawla, portfolio manager of Perceptive’s Credit Opportunity Funds (PCOF). With the larger raise, Chawla expects Perceptive to make 20 investments, including 9 that have already been given out to companies like C4 Therapeutics and Pear Therapeutics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.